Sunitigen-50

Packed:

50 mg / 28 Capsules

Manufacturer:

Hetero Labs Limited

Active ingredient:

Sunitinib

Sunitigen (Sunitinib) is indicated for:

  • Advanced and/or metastatic renal cell carcinoma (including cases where cytokine therapy has been ineffective).
  • Gastrointestinal stromal tumors (GISTs) when imatinib therapy has failed to produce the desired effect.
  • Unresectable or metastatic neuroendocrine tumors of the pancreas.
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Sunitigen-50”

Your email address will not be published. Required fields are marked *